PCI PHARMA SERVICES
PCI Pharma Services is an integrated full service provider, a proven and trusted partner to leading companies in the global healthcare industry. We offer unparalleled expertise and experience in taking compounds from the earliest stages of development through to successful commercialization, delivering speed-to-market and commercial success for our customers.
Our core services support each stage of the product lifecycle, including drug development, clinical trial supply, commercial launch and ongoing commercial supply. We partner with clients in providing innovative technologies, flexible solutions, and an integrated supply network supporting lifesaving medicines destined to over 100 countries around the world.
We support clients with a dedication to providing the industry’s leading experience, exemplified in our operational flexibility, delivery, and commitment to safety, supported by industry leading technologies and an exemplary quality and regulatory record. This has allowed us to be the partner of choice for leading pharmaceutical companies around the world, operating as a seamless extension of their business.
VIDEOS
CONTACT INFORMATION
PCI Pharma Services
3001 Red Lion Road
Philidelphia, PA 19114
UNITED STATES
Phone: 908-210-4029
Fax: 215-613-3601
Contact: Ed Malatesta
BROCHURES
- PCI Pharma Services ESG Report FY23
- Packaging Design And Development Services
- Late Stage Customization
- Frozen Packaging Solutions
- pci | bridge: Real-Time Supply Chain Information
- Environmental Social Governance
- Scalable Manufacturing Of Sterile Drug Products
- Advancing Your Product From Development To Commercialization
- Expedite Your Clinical Study
- Get Products Through Development, Commercialization, And Beyond
- An Introductory Guide To Clinical EU Qualified Person (QP) Services
- Dual Sourcing: Mitigating Risk In Your Supply Chain
- PCI Clinical Trial Services
- SMART First Human Dose (FHD)
FEATURED ARTICLES
- PCI Pharma Services And ChiRhoClin Partner To Prevent Shortage Of Critical Orphan Pancreatic Drug
- PCI Pharma Services Invests Over $365 Million In EU, US Facilities For Clinical And Commercial Supply Of Advanced Drug Delivery And Drug-Device Combination Products
- Optimising Pharmaceutical Processes: A Guide To Lyophilisation Cycle Development
- Reducing Time To First-In-Human Trials With Robotic SFF Services
- Construction And Validation Activities At The PCI Pharma Services Bedford, NH Campus Will Conclude Later This Year, With GMP Production Commencing In Early 2025
- Enhancing Sterility: The Crucial Role Of Isolators In Sterile Fill-Finish
- CDMO Support: Catalyst For Success In Early-Phase Drug Product Development And Manufacturing
- The Role Of CDMOs In Creating A More Sustainable Pharmaceutical Supply Chain
- Analytical Method Development In A High Potent Facility
- Advancing Your API To First Human Dose Trials More Efficiently
- Autoinjectors: A Revolutionary Leap In Drug Delivery
- Advantages Of Robotic Aseptic Processing
- Calling All Laureates In Oncology Drug Manufacturing
- Containment In A High Potent Manufacturing Facility
- Digital Transformation: A Critical Component For CDMOs
- Prefilled Syringes Market Trends: Improving Patient Experience
- The Growth Of Sterile Injectables
- High Potent Formulation Development In Oncology
- Pharma Research, Development, & Launches Save Lives — & The Earth
- Global Sterile Manufacturing & Lyophilization Capabilities Of Biologics